RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:RDHL.
$7.89 +0.06 (0.77%)
As of 03/08/2021 11:10:09 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.